The Cytotoxic Effect of PM 701 and its Fractions on Cell Proliferation of Breast Cancer Cells, McF7

Authors: Faten A. Khorshid

Abstract:

Breast cancer is the most common malignancy in the world among women. Many therapies have been designed to treat this disease. Mamectomy, chemotherapy and radiotherapy are still the main therapies of breast cancer. However, the results were unsatisfactory and still far from the ideal treatment. PM 701is a natural product, has anticancer activity. The bioactive fraction PMF and subfraction PMFK had been isolated from PM701. PM 701 and its fractions were proved to have a cytotoxic properties against different cancer cell lines. This article is directed for the further examination of lyophilized PM701 and its active fractions on the growth of breast cancer cells (MCF-7). PM 701, PMF or PMFK were adding to the cultural medium, where MCF-7 is incubated. PM 701, PMF or PMFK were able to inhibit significantly the proliferation of MCF-7 cells, Moreover these new agents were proved to induce apoptosis of the breast cancer cells; through its direct effect on the nuclei.

Keywords: Anticancer agent, breast carcinoma, MCF-7 cell line, PM 701

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1070133

References:

[1] Coufal, M., M.M. Maxwell, Russel, D.E. Amore, A.M. S.M. Altmann, Z.R. Hollingsworth, A.B. Young, D.E. Housman, and A.G. Kazantsev, 2007. Discovery of a novel small-molecule targeting selective clearance of mutant huntingtin fragments. J Biomol Screen, 12(3):351-60.
[2] He, X., and R.H. Liu, 2007. Triterpenoids Isolated from Apple Peels Have Potent Antiproliferative Activity and May Be Partially Responsible for Apple's Anticancer Activity. J. Agric. Food Chem., 55(11):4366-70.
[3] Widodo N., K. Kaur, B.G. Shrestha, Y. Takagi, T. Ishii, Wadhwa R. and S.C. Kaul, 2007. Selective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effect. Clin Cancer Res., 13(7):2298-306.
[4] Feng, L., L.F. Zhang , T.J. Yan, J. Jin, and W.Y. Tao, 2006. Studies on active substance of anticancer effect in Polygonum cuspidatum. Zhong Yao Cai., 29(7):689-691.
[5] Khorshid F.A., Shazly H., Al-Jefery A., and Osman A.A. Dose Escalation Phase I Study in Healthy Volunteers to Evaluate the Safety of a natural product PM 701. Int. J. of pharmacology and toxicology,5(3): 91-9, 2010.
[6] Grever, M. and B.Chabner, . Cancer drug discovery and development in cancer propels and practice of oncology. Cytotoxicity of some medicinal plant extracts used in Tanzanian traditional medicine. J.Ethnopharmacol., 1997 ,70:143-149.
[7] Moshref SS : PM701 A Highly Selective Anti Cancerous Agent Against L1210 Leukemic Cells: II - In Vivo Clinical And Histopathological Study. JKAU- Medical Sciences ,2007,Vol 14 (1), pp.85-99.
[8] Schwartsmann, G, Ratain, MJ, Cragg, GM, Wong, JE, Saijo, N, Parkinson, DR, Fujiwara, Y, Pazdur, R, Newman, DJ, Dagher, R, Di Leone, L :Anticancer drug discovery and development throughout the world. J. Clin. Oncol. 20 , 2002, (suppl):47S-59S.
[9] Khorshid, F.A., Mosherf, S.S. & Tawfiq, N.H. : An ideal selective anticancer agent in vitro, I- Tissue culture study of human lung cancer cells A549. JKAU-Medical Sciences, 12,3-19, 2005.
[10] Khorshid, F.A., : Preclinical evaluation of PM 701 in Experimental animals. International Journal of Pharmacology, 2008 ,4(6): 443-451, ISSN 1811-7775.
[11] El-Shahawy A, El-Sawi N., Backer W.S., Wadiah S. Backer, Khorshid F.A., and Geweely N.S. Spectral Analysis, Molecular Orbital Calculations And Antimicrobial Activity Of PMF-G Fraction Extracted From PM-701. Int. J. of Pharma and Bioscience, vol. 1(2): p 1-19, 2010.
[12] Khorshid FA, Moshref SS, Jamal Y. The Effect of PM 701 on Mice Leukemic Cells:I - Tissue Culture Study of L1210 (In Vitro) II - In Vivo Study on Mice, JKAU- Medical Sciences .Vol 13 (1), pp. 3-19, 2006.
[13] Khorshid FA. Osman AA. Abdulsattar E. Cytotoxicity of Bioactive fractions from PM 701. EJEAFChe, 8 (11), 2009.
[1091-1098].
[14] Ptak, A., Ludewig, G., Pak, A., Nadolna, W., Bochenek, M. & Gregoraszczuk, E.L. : Induction of cytochrome P450 1A1 in MCF-7 human breast cancer cells by 4-chlorobiphenyl (PCB3) and the effects of its hydroxylated metabolites on cellular apoptosis. Environment International (2009).
[15] Pollard JW, Walker JM.:Methods in Molecular Biology. vol. 5. Animal Cell Culture.Clifton, NJ: Human P, 1989, 2-10.
[16] Khorshid FA. Comparative Study of Keloid Formation in Animal Models, Med Sci Monit, 11(7): BR 212-219; 2005.
[17] Khorshid FA. Moshref SS. In Vitro Anticancer Agent, I - Tissue Culture Study of Human Lung Cancer Cells A549 II - Tissue Culture Study of Mice Leukemia Cells L1210. International Journal of Cancer Research 2 (4):330-344, 2006.
[18] Devarajan, E, Chen, J, Multani, AS et al.: Human breast cancer MCF-7 cell line contains inherently drug-resistance subclones with distinct genotypic and phenotypic features. Int. J. Oncol., 2002 , 20:913-920.
[19] Raouf GA, Khorshid FA; Kumosani T. :FT-IR Spectroscopy as a Tool for Identification of Apoptosis-Induced Structural Changes in A549 Cells Dry Samples Treated with PM 701. Int. J. Nano and Biomaterials, 2009 , Vol. 2, No. 1/2/3/4/5.
[20] Masuda, M.; Suzui, M. and Weinstein, I.B. : Effects of .epigallocatechin-3-gallate on growth, epidermal growth factor.receptor signaling pathways, gene expression, an .chemosensitivity in.human head and neck squamous cell.carcinoma cell lines. Clin Cancer Res., 2001,7:4220-9.
[21] Masuda,M.;Suzui,M.;Lim,J.T.and.Weinstein,I.B.: Epigallocatechin- 3- gallate inhibits.activation of HER-2/neu and downstream signaling .pathways in human head and neck and breast carcinoma cells. Clin Cancer Res., 2003, 9:3486-91.
[22] Huh,S.W.; Bae, S.M.; Kim, Y.W. et al. :Anticancer effects of (-)- .epigallocatechin-3- gallate on ovarian carcinoma cell lines. Gynecol. Oncol., 2004, 94 (3): 760-768.
[23] Chan, M.M.; Soprano, K.J.; Weinstein,K. and Fong,D,: Epigallocatechin-3-gallate delivers hydrogen peroxide to induce death.of ovarian cancer cells and enhances their cisplatin susceptibility. J Cell Physiol., 2006, 207: 389-96.
[24] Parkinson, A. : Biotransformation of xenobiotics. Klassen, C. D. eds. Cassarett and Doull-s Toxicology: The Basic Science of Poisons 5th ed. 1996:113-186 McGraw-Hill New York.